A recent study demonstrated that theacrine protected against dopaminergic degeneration in in vitro and in vivo models of PD by directly activating SIRT3, resulting in SOD2 deacetylation, the prevention of apoptosis, the reduction in ROS accumulation, and the restoration of mitochondrial dysfunction [72]. The gene discussed is SOD2; the disease is Parkinson disease.